| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.06 |